4.8 Review

LncRNAs has been identified as regulators of Myeloid-derived suppressor cells in lung cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Exosomal expression of RAB27A and its related lncRNA Lnc-RNA-RP11-510M2 in lung cancer

Ghada Mohamed Gamal El-Din et al.

Summary: This study examines the diagnostic role of serum exosomal RAB27A mRNA in lung cancer and evaluates the relationship between LncRNAs and lung cancer in the Egyptian population. The results suggest that RAB27A mRNA and Lnc-RNA-RP11-510M2.10 could be used as diagnostic and prognostic biomarkers for lung cancer.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)

Review Chemistry, Multidisciplinary

Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy

Qing Li et al.

Summary: Recent studies have shown that myeloid-derived suppressor cells (MDSCs) play a crucial role in immune regulation within the tumor microenvironment. Targeting the metabolic vulnerabilities of MDSCs could serve as a novel strategy to improve the efficacy of immunotherapy for cancer.

ACTA PHARMACOLOGICA SINICA (2022)

Editorial Material Medicine, General & Internal

Myeloid-Derived Suppressor Cells (MDSCs) in Haematology

Nikoleta Bizymi et al.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Pharmacology & Pharmacy

LncRNA SBF2-AS1: A Budding Star in Various Cancers

Fangshun Tan et al.

Summary: Long non-coding RNA (lncRNA) is a type of RNA that is over 200 nucleotides long and plays important roles in the development of various tumors. Among them, lncRNA SBF2-AS1 is involved in multiple cancers, including AML, BC, CC, ccRCC, CRC, DLBCL, ESCC, GC, glioma, GBM, HCC, LC, LUAD, NSCLC, OS, PC, PTC, and SCLC. Therefore, studying the underlying mechanisms of lncRNA SBF2-AS1 is of great significance for utilizing its therapeutic function in targeted treatments.

CURRENT PHARMACEUTICAL DESIGN (2022)

Article Multidisciplinary Sciences

Novel targets in rectal cancer by considering lncRNA-miRNA-mRNA network in response to Lactobacillus acidophilus consumption: a randomized clinical trial

Zohreh Khodaii et al.

Summary: This study aimed to explore the lncRNA-miR-mRNA network in rectal cancer patients' response to Lactobacillus acidophilus consumption. A group of differentially expressed miRs, lncRNAs, and genes were identified. The consumption of probiotics led to an increase in tumor suppressor gene expression and a decrease in oncogene expression. Additionally, strong correlations were observed between certain network components.

SCIENTIFIC REPORTS (2022)

Article Immunology

High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis

Giuseppe Bronte et al.

Summary: This study found that myeloid-derived suppressive-like cells (MDSCs) are strongly associated with primary resistance to immunotherapy in non-small cell lung cancer (NSCLC) patients. The exploratory analysis suggests that MDSC levels could potentially be used as a marker to select NSCLC patients who would benefit more from immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

Review Oncology

MicroRNAs/LncRNAs Modulate MDSCs in Tumor Microenvironment

Xiaocui Liu et al.

Summary: This article summarizes the regulation of miRNA/lncRNA on the differentiation, expansion, and immunosuppressive function of tumor MDSCs in the tumor microenvironment. The regulatory mechanisms of exosomal miRNA/lncRNA on tumor MDSCs are discussed, and the interaction of miRNA/lncRNA in modulating tumor MDSCs is also explored.

FRONTIERS IN ONCOLOGY (2022)

Article Engineering, Biomedical

Targeted regulation of tumor microenvironment through the inhibition of MDSCs by curcumin loaded self-assembled nano-filaments

Tingting Wang et al.

Summary: The study found that the use of curcumin as an MDSCs inhibitor can significantly inhibit tumor growth and improve the immune status of the tumor microenvironment, thus reducing the tumor burden.

MATERIALS TODAY BIO (2022)

Review Medicine, Research & Experimental

Association between long non-coding RNA HOTAIR polymorphism and lung cancer risk: A systematic review and meta-analysis

Chunlin Ke et al.

Summary: This meta-analysis investigated the association between SNP of lncRNA HOTAIR and lung cancer susceptibility. The results showed that the rs1899663 C>A polymorphism of lncRNA HOTAIR is a risk factor for lung cancer. This suggests that lncRNA HOTAIR may be important in lung cancer screening and prognosis prediction.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2022)

Article Oncology

Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer

Weilong Ye et al.

Summary: The prognostic model constructed in this study can accurately predict the survival period of non-small cell lung cancer patients and identified two low-risk immune pathways that are beneficial to patients. Furthermore, the association between gefitinib metabolism and cytochrome P450 and lipid metabolism was confirmed, and drugs that may be used to treat non-small cell lung cancer patients were screened.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner

Mi So Park et al.

Summary: GALNT3 has been identified as a tumor-suppressor in lung cancer, inhibiting tumor initiation and growth by reducing lung cancer cell self-renewal and preventing the creation of a favorable tumor microenvironment. This is achieved through mechanisms such as suppressing myeloid-derived suppressor cell infiltration and angiogenesis, and regulating the TNFR1-NF Kappa B and cMET-pAKT pathways.

CANCER LETTERS (2021)

Article Environmental Sciences

LncRNA RNCR3 promotes endothelial cell proliferation and inflammatory cytokine secretion via regulating miR-185-5p/cyclin D2 axis

Quanlong Hong et al.

Summary: The study shows that overexpression of RNCR3 in patients with atherosclerosis increases cell proliferation and inflammatory cytokine secretion, while the level of miR-185-5p is lower in their serum. Additionally, there is a negative correlation between miR-185-5p and RNCR3 expression in the serum of these patients.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)

Article Medicine, Research & Experimental

Downregulation of long non-coding RNA GACAT1 suppresses proliferation and induces apoptosis of NSCLC cells by sponging microRNA-422a

Youqing Zhong et al.

Summary: The study demonstrated that overexpression of GACAT1 in NSCLC was associated with poor outcomes, and downregulation of GACAT1 inhibited proliferation, induced apoptosis, and cell cycle arrest in NSCLC cell lines. Furthermore, GACAT1 was found to regulate the miR-422a and YY1 pathway in NSCLC cells, providing a potential therapeutic strategy for NSCLC treatment.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Review Cell Biology

LNCcation: lncRNA localization and function

Mary Catherine Bridges et al.

Summary: This review summarizes the current knowledge of subcellular localization of long noncoding RNAs (lncRNAs), factors controlling their localization, emerging themes, and discusses the implications of lncRNA localization on their function and cellular behavior, as well as opportunities for future research.

JOURNAL OF CELL BIOLOGY (2021)

Article Oncology

Long non-coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia

Zhenqing Tan et al.

Summary: This study revealed that lncRNA ANRIL is significantly increased in AML patients and associated with clinical features and prognosis. High expression of lncRNA ANRIL is correlated with low CR rate and shorter EFS and OS in AML patients.

MOLECULAR MEDICINE REPORTS (2021)

Article Oncology

Long non-coding RNA PITPNA-AS1 silencing suppresses proliferation, metastasis and epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting microRNA-32-5p

Gang Chen et al.

Summary: The study revealed that the high expression of PITPNA-AS1 in NSCLC and its silencing could inhibit the proliferation, invasion, and migration of lung cancer cells. By targeting miR-32-5p, PITPNA-AS1 played a significant role in regulating the expression levels of EMT-related proteins, suggesting its potential as a biomarker for NSCLC diagnosis and treatment.

MOLECULAR MEDICINE REPORTS (2021)

Review Pharmacology & Pharmacy

The biology, function, and applications of exosomes in cancer

Jinyi Liu et al.

Summary: Exosomes are cell-derived nanovesicles that play essential roles in intercellular communication, cancer progression, and drug delivery. They have potential applications in cancer diagnosis, treatment, and research.

ACTA PHARMACEUTICA SINICA B (2021)

Letter Oncology

LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2

Wei Lu et al.

Summary: In this study, it was found that lncRNA Snhg6 is highly expressed in tumor-derived MDSCs and promotes the differentiation of Mo-MDSCs by inhibiting the expression of EZH2 at the protein level. This finding may provide new insights and targets for anti-tumor immunotherapy targeting MDSCs.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Review Oncology

Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic

Amit Grover et al.

Summary: MDSCs are important regulators of immune responses in cancer, and their association with negative clinical outcomes makes them attractive therapeutic targets. However, the complex nature of MDSC biology presents a substantial challenge for therapeutic targeting. This review discusses the challenges and potential solutions in targeting MDSCs for therapeutic intervention.

CANCER DISCOVERY (2021)

Review Biochemistry & Molecular Biology

Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer

Bela Goyal et al.

Summary: MALAT1 is a widely studied lncRNA in cancer, playing an important role in tumorigenesis and development, localized in the periphery of nuclear speckles. Molecular tools have shown its diagnostic, prognostic, and therapeutic potential in various cancers.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Oncology

Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non-Small Cell Lung Cancer

Rui Li et al.

Summary: Loss of LKB1 leads to increased secretion of ELR+ CXC chemokines in NSCLC, promoting the enrichment of G-MDSCs and immunosuppression. Treatment with ATRA enhances tumor sensitivity to PD-1 blockade, suggesting a potential strategy for overcoming immunotherapy resistance in LKB1-deficient NSCLC.

CANCER RESEARCH (2021)

Review Oncology

Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition

Mana Taki et al.

Summary: Epithelial-mesenchymal transition (EMT) plays a critical role in tumor development by interacting with immune evasion mechanisms, leading to tumor progression. Combination therapy targeting EMT and immunosuppression may offer promising new therapeutic approaches in cancer treatment.

CLINICAL CANCER RESEARCH (2021)

Review Cell Biology

A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment

Francesca Hofer et al.

Summary: Research has shown that myeloid-derived suppressor cells play a crucial role in immune regulation within the tumor microenvironment, with their metabolic pathways and functions being essential for cancer progression.
Article Medicine, Research & Experimental

Long non-coding RNA NEAT1 regulates ferroptosis sensitivity in non-small-cell lung cancer

Hongxia Wu et al.

Summary: This study revealed the regulatory roles of NEAT1 on ACSL4 and ferroptosis-related proteins in NSCLC, highlighting its significant impact on enhancing ferroptosis sensitivity. These findings suggest that targeting NEAT1 or ACSL4 may be an effective therapeutic approach for treating NSCLC.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)

Review Critical Care Medicine

Myeloid-Derived Suppressor Cells (MDSCs) and the Immunoinflammatory Response to Injury (Mini Review)

Shannon R. Sayyadioskoie et al.

Summary: Myeloid-derived suppressor cells (MDSCs) exhibit marked expansion in acute inflammatory states, but gaps in knowledge exist regarding their functionality in trauma and sepsis, and their clinical significance remains unclear. While MDSCs play an important role in suppressing inflammatory responses, their accumulation may also lead to immune dysregulation and multiorgan failure risk.
Article Oncology

lncRNA LINC00473 promotes proliferation, migration, invasion and inhibition of apoptosis of non-small cell lung cancer cells by acting as a sponge of miR-497-5p

Shao-Hua Xu et al.

Summary: The study demonstrated that the overexpression of LINC00473 and low expression of miR-497-5p play important roles in the occurrence and development of lung cancer, promoting the malignant behavior of NSCLC cells through regulating proliferation, migration, invasion, as well as activating the ERK/p38 and MAPK signaling pathways.

ONCOLOGY LETTERS (2021)

Article Urology & Nephrology

LncRNA PVT1 accelerates LPS-induced septic acute kidney injury through targeting miR-17-5p and regulating NF-κB pathway

Wensheng Yuan et al.

Summary: PVT1 knockdown promoted cell viability, suppressed inflammatory response and apoptosis by regulating miR-17-5p expression and NF-kappa B pathway in LPS-stimulated HK-2 cells. MiR-17-5p was sponged by PVT1, and its inhibition weakened the impact of PVT1 deficiency on LPS-mediated injury of HK-2 cells.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2021)

Article Biochemistry & Molecular Biology

PVT1 and ZFAS1 lncRNAs expressions and their biomarker value in gastric cancer tissue sampling among Iranian population

Narges Dastmalchi et al.

Summary: PVT1 was significantly associated with lymph-node involvement, while ZFAS1 was significantly associated with lymph-node involvement and tumor size >5 cm. The ROC curve findings suggest that PVT1 and ZFAS1 may serve as potential biomarkers for gastric cancer detection and treatment.

MOLECULAR BIOLOGY REPORTS (2021)

Review Immunology

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Filippo Veglia et al.

Summary: MDSCs are pathologically activated cells with potent immunosuppressive activity, closely associated with poor clinical outcomes in diseases like cancer. Recent studies have identified key distinctions between MDSCs and classical neutrophils and monocytes, providing new insights into therapeutic targeting for cancer and autoimmune diseases through understanding their genomic and metabolic characteristics. Emerging data also suggest potential involvement of MDSCs in pregnancy, neonatal biology, and COVID-19.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Human Long Noncoding RNA Interactome: Detection, Characterization and Function

Marek Kazimierczyk et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Emerging roles of HOTAIR in human cancer

Chunjue Yuan et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Review Oncology

Myeloid-derived suppressor cells-new and exciting players in lung cancer

Zhenzhen Yang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Oncology

Oncogenic Role of PVT1 and Therapeutic Implications

Onayemi Titilayo Onagoruwa et al.

FRONTIERS IN ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin

Martina Ghetti et al.

MOLECULAR CANCER (2020)

Review Immunology

microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy

Elena Daveri et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy

Jackie E. Bader et al.

MOLECULAR CELL (2020)

Review Medical Laboratory Technology

Long noncoding RNA HOTAIRM1 in human cancers

Yuqiao Zhao et al.

CLINICA CHIMICA ACTA (2020)

Article Integrative & Complementary Medicine

LncRNA RNCR3 Promotes the Progression of HCC by Activating the Akt/GSK3β Signaling Pathway

Qi Xie et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)

Article Oncology

LncRNA PVT1 Regulates TRPS1 Expression Breast Cancer by Sponging miR-543

Hongtao Wang et al.

CANCER MANAGEMENT AND RESEARCH (2020)

Article Medicine, Research & Experimental

LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53

Jingjing Lu et al.

LIFE SCIENCES (2020)

Article Oncology

lncRNA PCAT19 negatively regulates p53 in non-small cell lung cancer

Xiaokai Zhang et al.

ONCOLOGY LETTERS (2019)

Article Critical Care Medicine

Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer

Yoshikane Yamauchi et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Article Genetics & Heredity

The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling

Haiyun Qian et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2018)

Review Genetics & Heredity

Towards a complete map of the human long non-coding RNA transcriptome

Barbara Uszczynska-Ratajczak et al.

NATURE REVIEWS GENETICS (2018)

Review Biochemistry & Molecular Biology

Nitric Oxide Signaling in T Cell-Mediated Immunity

Almudena Garcia-Ortiz et al.

TRENDS IN MOLECULAR MEDICINE (2018)

Article Biotechnology & Applied Microbiology

SIK1-LNC represses the proliferative, migrative, and invasive abilities of lung cancer cells

Liu Yang et al.

ONCOTARGETS AND THERAPY (2018)

Article Oncology

LncRNA MALAT1 negatively regulates MDSCs in patients with lung cancer

Qinfeng Zhou et al.

JOURNAL OF CANCER (2018)

Review Biochemistry & Molecular Biology

Regulation of iNOS on Immune Cells and Its Role in Diseases

Qingjie Xue et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Oncology

MALAT1: a potential biomarker in cancer

Zhi-Xing Li et al.

CANCER MANAGEMENT AND RESEARCH (2018)

Article Oncology

Urinary cell-free DNA as a prognostic marker for KRAS-positive advanced-stage NSCLC

F. Xie et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2018)

Article Medicine, General & Internal

miR-16-1-3p targets TWIST1 to inhibit cell proliferation and invasion in NSCLC

Q. Q. Feng et al.

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY (2018)

Review Oncology

Non-coding RNA networks in cancer

Eleni Anastasiadou et al.

NATURE REVIEWS CANCER (2018)

Article Medicine, Research & Experimental

Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery

Xiaosan Su et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2018)

Review Oncology

Long Noncoding RNA and Cancer: A New Paradigm

Arunoday Bhan et al.

CANCER RESEARCH (2017)

Review Genetics & Heredity

Unique features of long non-coding RNA biogenesis and function

Jeffrey J. Quinn et al.

NATURE REVIEWS GENETICS (2016)

Review Rheumatology

The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis

Yungang Wang et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)

Review Immunology

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

Vinit Kumar et al.

TRENDS IN IMMUNOLOGY (2016)

Review Multidisciplinary Sciences

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Vincenzo Bronte et al.

NATURE COMMUNICATIONS (2016)

Review Genetics & Heredity

The ENCODE Project and Perspectives on Pathways

Vinicius Tragante et al.

GENETIC EPIDEMIOLOGY (2014)

Review Oncology

Functions of lncRNA HOTAIR in lung cancer

Gregory Loewen et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)

Article Oncology

Myeloid-Derived Suppressor Cells in the Development of Lung Cancer

Myrna L. Ortiz et al.

CANCER IMMUNOLOGY RESEARCH (2014)

Review Oncology

History of myeloid-derived suppressor cells

James E. Talmadge et al.

NATURE REVIEWS CANCER (2013)

Article Critical Care Medicine

CD14+S100A9+ Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non-Small Cell Lung Cancer

Po-Hao Feng et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

Review Immunology

Myeloid-derived suppressor cells as regulators of the immune system

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2009)